Filed pursuant to Rule 424(b)(5)
Registration Statement No. 333-251393
PROSPECTUS SUPPLEMENT
(To Prospectus dated December 30, 2020)
$110,000,000
3.750% Fixed-to-Floating Rate Subordinated Notes due 2031
We are offering $110,000,000 aggregate principal amount of 3.750% fixed-to-floating rate subordinated notes due 2031 (the “Notes”) pursuant to this prospectus supplement and the accompanying prospectus. The Notes will be offered in minimum denominations of $1,000 and integral multiples of $1,000 in excess thereof. The Notes will mature on September 1, 2031 (the “Maturity Date”). From and including the date of original issuance to, but excluding September 1, 2026 or the date of earlier redemption (the “fixed rate period”), the Notes will bear interest at an initial rate of 3.750% per annum, payable semi-annually in arrears on March 1 and September 1 of each year, commencing on March 1, 2022. The last interest payment date for the fixed rate period will be September 1, 2026. From and including September 1, 2026 to, but excluding, the Maturity Date or the date of earlier redemption (the “floating rate period”), the Notes will bear interest at a floating rate per annum equal to the Benchmark rate (which is expected to be Three-Month Term SOFR), each as defined and subject to the provisions described under “Description of the Notes — Interest” in this prospectus supplement, plus 310 basis points, payable quarterly in arrears on March 1, June 1, September 1 and December 1 of each year, commencing on December 1, 2026. Notwithstanding the foregoing, if the Benchmark rate is less than zero, the Benchmark rate will be deemed to be zero.
We may, at our option, beginning with the interest payment date of September 1, 2026 and on any interest payment date thereafter, redeem the Notes, in whole or in part. The Notes will not otherwise be redeemable by us prior to maturity, unless certain events occur, as described under “Description of the Notes — Redemption” in this prospectus supplement. The redemption price for any redemption is 100% of the principal amount of the Notes, plus accrued and unpaid interest thereon to, but excluding, the date of redemption. Any early redemption of the Notes will be subject to the receipt of the approval of the Board of Governors of the Federal Reserve System (the “Federal Reserve”) to the extent then required under applicable laws or regulations, including capital regulations.
The Notes will be unsecured subordinated obligations, will rank pari passu, or equally, with all of our future unsecured subordinated debt and will be junior to all of our existing and future senior debt. The Notes will be structurally subordinated to all existing and future liabilities of our subsidiaries and will be effectively subordinated to our existing and future secured indebtedness. There will be no sinking fund for the Notes. The Notes will be obligations of Hanmi Financial Corporation (“Hanmi”) only and will not be obligations of, and will not be guaranteed by, any of Hanmi’s subsidiaries. For a more detailed description of the Notes, see “Description of the Notes.”
Prior to this offering, there has been no public market for the Notes. The Notes will not be listed on any securities exchange or included in any automated quotation system.
The Notes are not deposits and are not insured by the Federal Deposit Insurance Corporation (the “FDIC”) or any other governmental agency. The Notes are ineligible as collateral for a loan or extension of credit from Hanmi or any of its subsidiaries. None of the U.S. Securities and Exchange Commission (the “SEC”), the FDIC, the Federal Reserve, the California Department of Financial Protection and Innovation (the “DFPI”) or any other bank regulatory agency or any state securities commission has approved or disapproved of the Notes or passed upon the adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.
Investing in the Notes involves risks. See “Risk Factors” beginning on page S-6 of this prospectus supplement and those risk factors in the documents incorporated by reference in this prospectus supplement and the accompanying prospectus.
| | | | | | | | |
| | Per Note | | | Total | |
Public offering price(1) | | | 100.00 | % | | $ | 110,000,000 | |
Underwriting discount(2) | | | 1.25 | % | | $ | 1,375,000 | |
Proceeds, before expenses, to us | | | 98.75 | % | | $ | 108,625,000 | |
(1) | Plus accrued interest, if any, from the original issue date. |
(2) | See “Underwriting” in this prospectus supplement for details. |
The underwriters expect to deliver the Notes to purchasers in book-entry form through the facilities of The Depository Trust Company, against payment on or about August 20, 2021. See “Underwriting” in this prospectus supplement for details.
Joint Book-Running Managers
| | |
Piper Sandler | | Keefe, Bruyette & Woods |
| | A Stifel Company |
Co-Managers
| | |
Janney Montgomery Scott | | Wedbush Securities |
The date of this prospectus supplement is August 18, 2021.